The Children's Hospital Foundation of Manitoba
Welcome,         Profile    Billing    Logout  
 10 Trials 
18 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wood, Robert
OUtMATCH, NCT03881696: Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants

Hourglass Jul 2023 - Dec 2023 : Data readout from P3 OUtMATCH trial for food allergy
Active, not recruiting
3
471
US
Omalizumab, Xolair®, Placebo for Omalizumab, Placebo, Multi-Allergen Oral Immunotherapy, Multi-Allergen OIT, Placebo for Multi-Allergen Oral Immunotherapy, Placebo for Multi-Allergen OIT, Double-Blind Placebo-Controlled Food Challenge Based Treatment, DBPCFC Based Treatment
National Institute of Allergy and Infectious Diseases (NIAID), Genentech, Inc., Novartis Pharmaceuticals, Rho Federal Systems Division, Inc.
Peanut Allergy, Multi-food Allergy
03/23
06/25
NCT05678959: Long-term Extension Study of Ligelizumab in Food Allergy

Active, not recruiting
3
163
Europe, Canada, Japan, US, RoW
Ligelizumab 120 mg, Ligelizumab 240 mg
Novartis Pharmaceuticals
Food Allergy
02/25
02/25
NCT03462030: Baked Milk Oral Immunotherapy for Cow's Milk Allergy

Completed
2
41
US
Baked non-fat cow's milk powder, Investigational New Drug (IND) 17114, Placebo: Tapioca Powder
Johns Hopkins University, Myra Reinhardt Foundation, La Jolla Institute for Allergy & Immunology
Cow's Milk Allergy
01/21
02/24
NCT05432388 / 2021-006950-30: Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts

Active, not recruiting
2
76
US
remibrutinib, (LOU064), placebo
Novartis Pharmaceuticals, Novartis Pharma AG
Allergy, Peanut
03/25
03/25
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26
adored, NCT05003804: Allergic Disease Onset Prevention Study

Active, not recruiting
1/2
264
US, RoW
STMC-103H, Placebo
Siolta Therapeutics, Inc.
Atopic Dermatitis, Type 1 Hypersensitivity
11/24
10/25
NCT03019328: Early Peanut Introduction: Translation to Clinical Practice

Completed
N/A
333
US
Peanut in diet
Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID), Massachusetts General Hospital
Peanut Allergy
10/22
03/23
SUNBEAM, NCT04798079: Systems Biology of Early Atopy

Recruiting
N/A
2500
US
National Institute of Allergy and Infectious Diseases (NIAID), Consortium for Food Allergy Research, Rho Federal Systems Division, Inc.
Allergic Diseases, Food Allergy, Atopic Dermatitis
09/28
09/28
Shreffler, Wayne G
OUtMATCH, NCT03881696: Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants

Hourglass Jul 2023 - Dec 2023 : Data readout from P3 OUtMATCH trial for food allergy
Active, not recruiting
3
471
US
Omalizumab, Xolair®, Placebo for Omalizumab, Placebo, Multi-Allergen Oral Immunotherapy, Multi-Allergen OIT, Placebo for Multi-Allergen Oral Immunotherapy, Placebo for Multi-Allergen OIT, Double-Blind Placebo-Controlled Food Challenge Based Treatment, DBPCFC Based Treatment
National Institute of Allergy and Infectious Diseases (NIAID), Genentech, Inc., Novartis Pharmaceuticals, Rho Federal Systems Division, Inc.
Peanut Allergy, Multi-food Allergy
03/23
06/25
NCT05363670: Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma

Completed
2
18
US
ARS-1, Albuterol MDI, Placebo
ARS Pharmaceuticals, Inc.
Asthma
02/24
02/24
NCT05496465: Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria Flares

Completed
2
24
US
ARS-1, Placebo
ARS Pharmaceuticals, Inc.
Urticaria
02/24
02/24
APTITUDE, NCT04492683 / 2019-004523-21: Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children

Recruiting
2
230
Europe, Canada, US
DBV1605
DBV Technologies
Cow's Milk Allergy
03/24
03/24
NCT04222491: Food Oral Immunotherapy for Peanut Allergy

Enrolling by invitation
2
500
US
Peanut oral immunotherapy, Peanut flour, Peanut allergen powder
Massachusetts General Hospital
Peanut Allergy
06/25
06/26
NCT05432388 / 2021-006950-30: Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts

Active, not recruiting
2
76
US
remibrutinib, (LOU064), placebo
Novartis Pharmaceuticals, Novartis Pharma AG
Allergy, Peanut
03/25
03/25
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26
NCT03936998: VE416 for Treatment of Food Allergy

Recruiting
1/2
60
US
Vancomycin plus VE416 before PNOIT, Vancomycin plus VE416 with PNOIT, Placebo plus VE416 with PNOIT, Placebo plus placebo with PNOIT
Massachusetts General Hospital, Vedanta Biosciences, Inc.
Peanut Allergy
11/23
01/24
SUNBEAM, NCT04798079: Systems Biology of Early Atopy

Recruiting
N/A
2500
US
National Institute of Allergy and Infectious Diseases (NIAID), Consortium for Food Allergy Research, Rho Federal Systems Division, Inc.
Allergic Diseases, Food Allergy, Atopic Dermatitis
09/28
09/28
Lizzio, Katie
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wood, Robert
OUtMATCH, NCT03881696: Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants

Hourglass Jul 2023 - Dec 2023 : Data readout from P3 OUtMATCH trial for food allergy
Active, not recruiting
3
471
US
Omalizumab, Xolair®, Placebo for Omalizumab, Placebo, Multi-Allergen Oral Immunotherapy, Multi-Allergen OIT, Placebo for Multi-Allergen Oral Immunotherapy, Placebo for Multi-Allergen OIT, Double-Blind Placebo-Controlled Food Challenge Based Treatment, DBPCFC Based Treatment
National Institute of Allergy and Infectious Diseases (NIAID), Genentech, Inc., Novartis Pharmaceuticals, Rho Federal Systems Division, Inc.
Peanut Allergy, Multi-food Allergy
03/23
06/25
NCT05678959: Long-term Extension Study of Ligelizumab in Food Allergy

Active, not recruiting
3
163
Europe, Canada, Japan, US, RoW
Ligelizumab 120 mg, Ligelizumab 240 mg
Novartis Pharmaceuticals
Food Allergy
02/25
02/25
NCT03462030: Baked Milk Oral Immunotherapy for Cow's Milk Allergy

Completed
2
41
US
Baked non-fat cow's milk powder, Investigational New Drug (IND) 17114, Placebo: Tapioca Powder
Johns Hopkins University, Myra Reinhardt Foundation, La Jolla Institute for Allergy & Immunology
Cow's Milk Allergy
01/21
02/24
NCT05432388 / 2021-006950-30: Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts

Active, not recruiting
2
76
US
remibrutinib, (LOU064), placebo
Novartis Pharmaceuticals, Novartis Pharma AG
Allergy, Peanut
03/25
03/25
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26
adored, NCT05003804: Allergic Disease Onset Prevention Study

Active, not recruiting
1/2
264
US, RoW
STMC-103H, Placebo
Siolta Therapeutics, Inc.
Atopic Dermatitis, Type 1 Hypersensitivity
11/24
10/25
NCT03019328: Early Peanut Introduction: Translation to Clinical Practice

Completed
N/A
333
US
Peanut in diet
Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID), Massachusetts General Hospital
Peanut Allergy
10/22
03/23
SUNBEAM, NCT04798079: Systems Biology of Early Atopy

Recruiting
N/A
2500
US
National Institute of Allergy and Infectious Diseases (NIAID), Consortium for Food Allergy Research, Rho Federal Systems Division, Inc.
Allergic Diseases, Food Allergy, Atopic Dermatitis
09/28
09/28
Shreffler, Wayne G
OUtMATCH, NCT03881696: Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants

Hourglass Jul 2023 - Dec 2023 : Data readout from P3 OUtMATCH trial for food allergy
Active, not recruiting
3
471
US
Omalizumab, Xolair®, Placebo for Omalizumab, Placebo, Multi-Allergen Oral Immunotherapy, Multi-Allergen OIT, Placebo for Multi-Allergen Oral Immunotherapy, Placebo for Multi-Allergen OIT, Double-Blind Placebo-Controlled Food Challenge Based Treatment, DBPCFC Based Treatment
National Institute of Allergy and Infectious Diseases (NIAID), Genentech, Inc., Novartis Pharmaceuticals, Rho Federal Systems Division, Inc.
Peanut Allergy, Multi-food Allergy
03/23
06/25
NCT05363670: Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma

Completed
2
18
US
ARS-1, Albuterol MDI, Placebo
ARS Pharmaceuticals, Inc.
Asthma
02/24
02/24
NCT05496465: Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria Flares

Completed
2
24
US
ARS-1, Placebo
ARS Pharmaceuticals, Inc.
Urticaria
02/24
02/24
APTITUDE, NCT04492683 / 2019-004523-21: Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children

Recruiting
2
230
Europe, Canada, US
DBV1605
DBV Technologies
Cow's Milk Allergy
03/24
03/24
NCT04222491: Food Oral Immunotherapy for Peanut Allergy

Enrolling by invitation
2
500
US
Peanut oral immunotherapy, Peanut flour, Peanut allergen powder
Massachusetts General Hospital
Peanut Allergy
06/25
06/26
NCT05432388 / 2021-006950-30: Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts

Active, not recruiting
2
76
US
remibrutinib, (LOU064), placebo
Novartis Pharmaceuticals, Novartis Pharma AG
Allergy, Peanut
03/25
03/25
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26
NCT03936998: VE416 for Treatment of Food Allergy

Recruiting
1/2
60
US
Vancomycin plus VE416 before PNOIT, Vancomycin plus VE416 with PNOIT, Placebo plus VE416 with PNOIT, Placebo plus placebo with PNOIT
Massachusetts General Hospital, Vedanta Biosciences, Inc.
Peanut Allergy
11/23
01/24
SUNBEAM, NCT04798079: Systems Biology of Early Atopy

Recruiting
N/A
2500
US
National Institute of Allergy and Infectious Diseases (NIAID), Consortium for Food Allergy Research, Rho Federal Systems Division, Inc.
Allergic Diseases, Food Allergy, Atopic Dermatitis
09/28
09/28
Lizzio, Katie
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26

Download Options